The bridge is already built: management walks investors from today's numbers to a bigger business using only pieces alre
The model's full reasoning — Q4 2022 call → NOWe need to determine if management's forward-looking explanation for the next year is built primarily out of specific pieces already secured or in motion, such that the reported results understate the locked-in business. The question asks for a YES/NO based on the transcript. We need to analyze the transcript for management's statements about the coming year. Key points: They mention upcoming launches, approvals, data readouts, etc. But are these "already secured or in motion"? For example, aflibercept 8 mg is submitted for approval, potential U.S. launch in late August. That's pending approval, not yet secured. Dupixent has potential regulatory approvals in new diseases, geographies, younger populations—these are pending. COPD readout is upcoming, not secured. Oncology pipeline: they expect regulatory submissions for odronextamab and linvoseltamab in second half, but those are submissions, not approvals. They mention initiating Phase 3 studies, etc. They also mention next-gen COVID antibody entering clinical development later this year—that's early stage. The question asks: does management build the forward story primarily out of specific pieces already secured or in motion? The pieces they mention are mostly pending approvals, data readouts, and clinical trials. They are not yet committed or contracted. For example, the launch of aflibercept 8 mg is contingent on FDA approval. The Dupixent approvals are pending. The COPD readout is a data readout, not a secured revenue stream. The oncology submissions are not yet approved. So these are not "already secured" in the sense of contracts, orders, or committed rollouts. Also, they mention "we expect 2023 to be another notable year with significant incremental progress" but that's general. They talk about "potential regulatory approvals" and "we look forward to the upcoming readout" etc. So the forward story is largely based on pipeline and potential approvals, not on already locked-in business. The question also asks if the results just reported understate the business already locked in. Management does not present a walk of specific secured pieces that will ramp up. Instead, they talk about opportunities and expectations. Thus, the answer is NO. We need to be careful: Are there any pieces already in motion? For example, Libtayo was approved in November 2022, and they are launching it.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
EVGO · Q2 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, making current results understate the locked-in...YES The transcript shows management framing the next-year outlook around the newly announced, signed GM-Pilot eXtend deal (up to 2,000 stalls at 500 locations, with EVgo procuring, constructing, operating, and maintaining, delivering both near-term revenue and longer-term contracted cash flows that already exceed IRR hurdles) plus the Delta supply agreement (1,000+ chargers for 2,000 stalls through 2026) and the GSA BPA (which removes procurement friction for federal fleets). These pieces are presented as already committed and in motion, with explicit timing for revenue ramp in H2 2022 and into 202 3, while the company notes it has baked some of the PFJ contribution into its 2022 guidance. The structure treats these secured elements as the primary bridge from today’s numbers to a meaningfully larger business, rather than relying on pipeline, demand, or future bids. Other items (NEVI solicitations, fleet pilots ) are secondary and contingent, but the core forward posture is built on the named, already-executed contracts and programs. Current results visibly understate the locked-in trajectory because the eXtend model shifts cash flows forward and the secured stalls/contracts are only beginning to flow.
BRBR · Q4 2023 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing fiscal '24 growth as driven by concrete, already-committed pieces: the two co-man additions from '23 that are scaling, the Michael Foods greenfield facility that starts up in December and will be a "much larger contributor" in the second half of '24, the 20 %+ production growth plan (40 % from new co-mans in '24, 40 % from lapping prior adds, 20 % from existing), and the restart of shake promotions in Q2 plus marketing step-up in Q4 once target weeks of supply are reached. These are presented as nameable, scheduled 2024 actions that will enable double-digit volume growth for both Premier Protein and Dymatize, with the current-year results (22 % sales growth under capacity constraints) treated as a base that the locked-in capacity ramp will visibly outgrow.
MEC · Q3 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing 2023 growth primarily around specific, already secured or in-motion pieces: the electric side-by-side family of parts (production fully launching in 2023), the reshoring project for the commercial vehicle customer (production scheduled to start early 2023), the high-value ag takeover project (already awarded), incremental business on the light-duty truck platform, and the new industrial infrastructure customer relationship (quickly supported and expected to grow). These are presented as nameable, committed items whose contributions are beginning or ramping over the coming year.